Erratum: Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25 (JNCI J Natl Cancer Inst (2014) 106: 8 (dju164) DOI: 10.1093/jnci/dju164);Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25

Journal of the National Cancer Institute

Volumn 106, Issue 8, 2014, Pages

  Cheung, Patrick ^a   Faria, Sergio ^b   Ahmed, Shahida ^c   Chabot, Pierre ^d   Greenland, Jonathan ^e   Kurien, Elizabeth ^f   Mohamed, Islam ^g   Wright, James R ^h   Hollenhorst, Helmut ⁱ   De Metz, Catherine ^j   Campbell, Holly ^k   Vu, Thi Toni ^l   Karvat, Anand ^g   Wai, Elaine S ^g   Ung, Yee C ^a   Goss, Glenwood ^m   Shepherd, Frances A ⁿ   O'Brien, Patti ^j   Ding, Keyue ^j   O'Callaghan, Chris ^j  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c CANCERCARE MANITOBA   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e Dr H Bliss Murphy Cancer Clinic   (Canada)

^f TOM BAKER CANCER CENTRE   (Canada)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^j QUEEN S UNIVERSITY   (Canada)

^k SAINT JOHN REGIONAL HOSPITAL   (Canada)

^l NOTRE DAME HOSPITAL   (Canada)

^m OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁿ UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED HYPOFRACTIONATED THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; COUGHING; DYSPNEA; EARLY CANCER; ESOPHAGITIS; FATIGUE; FEMALE; FOLLOW UP; HEARTBURN; HEMOPTYSIS; HUMAN; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; SURVIVAL RATE; THORAX PAIN; TREATMENT OUTCOME; CANADA; CANCER STAGING; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; STATISTICS;

ADULT; AGED; CANADA; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 84907017981     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju430     Document Type: Erratum

References (11)

1. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001;56(8):628-638.
2. Cheung PC, Yeung LT, Basrur V, Ung YC, Balogh J, Danjoux CE. Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;54(4):1014-1023.
3. Faria SL, Souhami L, Portelance L, et al. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol. 2006;1:42.
4. Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol. 1996;41(1):41-44.
5. Soliman H, Cheung P, Yeung L, et al. Accelerated hypofractionated radiotherapy for early-stage non-small-cell lung cancer: long-term results. Int J Radiat Oncol Biol Phys. 2011;79(2):459-465.
6. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205-216.
7. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076.
8. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol. 2012;13(8):802-809.
9. Dunlap NE, Yang W, McIntosh A, et al. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Rad Oncol Biol Phys. 2012;84(5):1071-1077.
10. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833-4839.
11. Bogart JA, Hodgson L, Seagren SL, et al. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol. 2010;28(2):202-206.